[{"id":"50e34af4-899e-42bc-acc2-0b1a7ae0ee45","acronym":"CRB-601-01","url":"https://clinicaltrials.gov/study/NCT06603844","created_at":"2025-02-26T08:20:15.107Z","updated_at":"2025-02-26T08:20:15.107Z","phase":"Phase 1/2","brief_title":"First-in-human Study of CRB-601-01 to Treat Patients with Advanced Solid Tumor.","source_id_and_acronym":"NCT06603844 - CRB-601-01","lead_sponsor":"Corbus Pharmaceuticals Inc.","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CRB-601"],"overall_status":"Recruiting","enrollment":" Enrollment 156","initiation":"Initiation: 12/04/2024","start_date":" 12/04/2024","primary_txt":" Primary completion: 11/01/2026","primary_completion_date":" 11/01/2026","study_txt":" Completion: 12/01/2026","study_completion_date":" 12/01/2026","last_update_posted":"2024-12-24"}]